Biofilms and Breast Implants – Scientific Guidance to Prevention and Treatment
Breast implant based procedures remains one of the most popular cosmetic procedures performed by plastic surgeons. For the past 20 years, we have previously studied and described methods to optimize breast pocket irrigation. In a recent preliminary ASERF study (submitted to ASJ) we studied the in vitro efficacy of different irrigating agents on planktonic bacteria. In the past 10 years the morbidity of biofilm mediated implant infection has become front and center, particularly with the evolving story related to the pathogenesis of breast implant associated anaplastic large cell lymphoma.
The efficacy of popular clinical agents is not well studied nor understood, specifically as they pertain to their effect on biofilm, and when an anti-biofilm effect outweighs anti-planktonic activity. The critical knowledge gap is how to not only prev
The purpose of this study is:
Scientifically evaluate different breast implant irrigating agents specifically for biofilm prevention
Evaluate the same agents for established biofilm eradication
Related Projects
- Published on Jun 24, 2024A delayed seroma around breast implants is the most common clinical presentation of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL).
- Published on Jun 10, 2024A subset of females with breast implants have reported a myriad of nonspecific systemic symptoms collectively termed systemic symptoms associated with breast implants (SSBI).
- Published on Jul 11, 2023Aesthetic surgery fellowship applications were consolidated under the San Francisco Match in 2018. The impact of these changes on aesthetic program and applicant numbers had not yet been investigated.